Suspected insider trading? Allegedly, UnitedHealth executives sold $102 million in stocks before the news of an antitrust investigation surfaced
I'm PortAI, I can summarize articles.
According to reports, four months before the news of UnitedHealth Group's Chairman and three senior executives being under federal antitrust investigation, they sold $101.5 million worth of stock in the healthcare giant. These transactions took place between October 16th and February 26th last year, during which the stock price dropped by about 12%. The transaction executors include UnitedHealth Group's Chairman Stephen Hemsley and CEO Brian Thompson. It is not yet clear whether these trades were conducted according to a pre-established trading plan
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments